- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: lapatinib ditosylate
Total 1747 results
-
Ruijin HospitalRecruiting
-
GlaxoSmithKlineCompletedNeoplasms, Head and NeckSpain, Peru, France, United States, Netherlands, India, Hungary, United Kingdom, Canada
-
Peking University Cancer Hospital & InstituteRecruiting
-
Taivex Therapeutics CorporationTerminatedAdvanced Refractory Solid TumorsTaiwan
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
Lei LiCompletedChemotherapy | Recurrent Cervical Carcinoma | Apatinib | Targeted Therapy | Persistent Advanced Cervical Carcinoma | Vascular Endothelial Growth Factor 2 InhibitorChina
-
Wuhan Union Hospital, ChinaWithdrawnColorectal Cancer | Chemotherapy | Angiogenesis
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.Unknown
-
Georgetown UniversityGlaxoSmithKline; Millennium Pharmaceuticals, Inc.Terminated
-
GlaxoSmithKlineCompletedMetastatic Cervical Cancer | Neoplasms, Uterine CervixUnited States, Germany, Spain, Thailand, Belgium, Italy, Argentina, Canada, Ireland, India, France, Estonia, Mexico
-
Institute of Cancer Research, United KingdomGlaxoSmithKlineCompletedBreast CancerUnited Kingdom
-
Taivex Therapeutics CorporationActive, not recruitingAdvanced Refractory Solid TumorsTaiwan
-
Taivex Therapeutics CorporationCompletedAdvanced Refractory Solid TumorsTaiwan
-
Huazhong University of Science and TechnologyUnknown
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingEsophageal Cancer by AJCC V8 StageChina
-
Peking UniversityJiangsu HengRui Medicine Co., Ltd.Recruiting
-
The First Affiliated Hospital of Zhengzhou UniversityRecruiting
-
Peking Union Medical College HospitalCompletedApatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer (ACABC)Cholangiocarcinoma | Hepatobiliary Neoplasm | Biliary Tract Cancer | BiomarkerChina
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastCanada, Netherlands, United States, Spain, Korea, Republic of
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompleted
-
SCRI Development Innovations, LLCSanofi; GlaxoSmithKline; NovartisTerminatedMetastatic Breast Cancer With Intracranial MetastasesUnited States
-
University of Wisconsin, MadisonGlaxoSmithKlineCompletedMetastatic Colorectal CancerUnited States
-
Daiichi Sankyo Co., Ltd.Active, not recruitingAdult T-cell Leukemia/LymphomaJapan
-
Ruijin HospitalActive, not recruitingGastric and Gastroesophageal Junction (GEJ) AdenocarcinomaChina
-
Shoucheng MaUnknownColorectal NeoplasmsChina
-
Novartis PharmaceuticalsCompletedMetastatic Non-Small Cell Lung CancerUnited States
-
Peking Union Medical College HospitalCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Dana-Farber Cancer InstituteCompleted
-
New York State Psychiatric InstituteIntra-Cellular Therapies, Inc.Terminated
-
Tianjin Hemay Oncology Pharmaceutical Co., LtdRecruiting
-
GlaxoSmithKlineCompleted
-
Azienda Ospedaliera Ordine Mauriziano di TorinoUnknownMetastatic Breast CancerItaly
-
NovartisApproved for marketingNeoplasms, BreastChina, United States, Spain, United Kingdom, Austria, Belgium, Estonia, Canada, Netherlands, Singapore, Australia, Germany, Israel, Italy, Poland, Russian Federation, Sweden, Switzerland, Taiwan, Thailand, Brazil, Denmark, Ireland, Korea... and more
-
GlaxoSmithKlineCompleted
-
Sunshine Lake Pharma Co., Ltd.Not yet recruitingEsophageal Cancer | Advanced Solid TumorChina
-
Novartis PharmaceuticalsWithdrawnNon-small Cell Lung Carcinoma (NSCLC)
-
Asan Medical CenterUnknownCancer | Lung Cancer Metastatic | MET Gene MutationKorea, Republic of
-
Jiangsu HengRui Medicine Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesTerminated
-
Beijing HospitalChinese Society of Clinical OncologyRecruiting
-
The Lymphoma Academic Research OrganisationDaiichi SankyoActive, not recruitingStudy of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell LymphomaLymphoma, B-CellFrance, Belgium
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Sun Yat-sen UniversityNot yet recruitingNSCLC | Non-small Cell Lung CancerChina
-
GlaxoSmithKlineCompletedNeoplasms, ColorectalUnited States
-
UNICANCERGlaxoSmithKlineCompletedMetastatic Breast Cancer | 70 Years Old Patients and Over | After One Line of Chemotherapy With TrastuzumabFrance
-
Istituto Clinico HumanitasCompleted
-
GlaxoSmithKlineCompletedSquamous Cell Carcinoma of Head and NeckSpain, France, Peru, India, Greece
-
Timothy Burns, MD, PHDNovartisRecruitingNon-small Cell Lung CancerUnited States
-
Novartis PharmaceuticalsWithdrawnCarcinoma | Non-Small-Cell Lung Cancer
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.Not yet recruitingMetastatic Biliary Tract Cancer | Locally Advanced Biliary Tract CancerChina